The stock of Zoetis Inc (NYSE: ZTS) has increased by 1073754 when compared to last closing price of 157.34.Despite this, the company has seen a loss of -5.49% in its stock price over the last five trading days. zacks.com reported 2025-06-20 that Investors interested in stocks from the Medical – Drugs sector have probably already heard of Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Zoetis (ZTS).
Is It Worth Investing in Zoetis Inc (NYSE: ZTS) Right Now?
Zoetis Inc (NYSE: ZTS) has a price-to-earnings ratio of 27.90x that is above its average ratio. Additionally, the 36-month beta value for ZTS is 0.94. There are mixed opinions on the stock, with 10 analysts rating it as a “buy,” 4 rating it as “overweight,” 6 rating it as “hold,” and 0 rating it as “sell.”
The public float for ZTS is 444.77M and currently, short sellers hold a 2.37% ratio of that float. The average trading volume of ZTS on June 24, 2025 was 2.93M shares.
ZTS’s Market Performance
ZTS stock saw a decrease of -5.49% in the past week, with a monthly decline of -4.08% and a quarterly a decrease of -4.79%. The volatility ratio for the week is 2.40%, and the volatility levels for the last 30 days are 1.69% for Zoetis Inc (ZTS). The simple moving average for the past 20 days is -5.75% for ZTS’s stock, with a -8.86% simple moving average for the past 200 days.
Analysts’ Opinion of ZTS
Many brokerage firms have already submitted their reports for ZTS stocks, with Stifel repeating the rating for ZTS by listing it as a “Hold.” The predicted price for ZTS in the upcoming period, according to Stifel is $160 based on the research report published on June 18, 2025 of the current year 2025.
Leerink Partners, on the other hand, stated in their research note that they expect to see ZTS reach a price target of $215. The rating they have provided for ZTS stocks is “Outperform” according to the report published on December 02nd, 2024.
BTIG Research gave a rating of “Buy” to ZTS, setting the target price at $220 in the report published on July 25th of the previous year.
ZTS Trading at -2.57% from the 50-Day Moving Average
After a stumble in the market that brought ZTS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.45% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ZTS starting from Lagano Roxanne, who sale 652 shares at the price of $170.00 back on Jun 03 ’25. After this action, Lagano Roxanne now owns 15,129 shares of Zoetis Inc, valued at $110,840 using the latest closing price.
Stock Fundamentals for ZTS
Current profitability levels for the company are sitting at:
- 0.37 for the present operating margin
- 0.7 for the gross margin
The net margin for Zoetis Inc stands at 0.27. The total capital return value is set at 0.32. Equity return is now at value 51.85, with 17.70 for asset returns.
Based on Zoetis Inc (ZTS), the company’s capital structure generated 0.59 points at debt to capital in total, while cash flow to debt ratio is standing at 0.44. The debt to equity ratio resting at 1.45. The interest coverage ratio of the stock is 15.55.
Currently, EBITDA for the company is 3.87 billion with net debt to EBITDA at 1.26. When we switch over and look at the enterprise to sales, we see a ratio of 7.97. The receivables turnover for the company is 6.82for trailing twelve months and the total asset turnover is 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.74.
Conclusion
In conclusion, Zoetis Inc (ZTS) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
